Resverlogix Corp

(RVXCF)

By |

Profile

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing RVX-208, a molecule selective inhibit BET domain inhibitor for the treatment of patients with cardiovascular, diabetes mellitus, Alzheimer\'s & chronic kidney disease.

Contact Information

Website: www.resverlogix.com
Email: sarah@resverlogix.com
Main Phone: +1 403 254-9252
Address: 4820 Richard Road S.W.
Address 2: Suite 300
State: AB
City / Town: Calgary
Country: CAN
Postal Code: T3E 6L1

Issuer Information

Exchange: OTO
Employees: 22
NAICS: Biological Produ
$ 1.63 $ -0.0478 (-2.84%)
Last Price 1.63 Change $ -0.0478 Change % -2.84 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 1.73 High 1.73 Low 1.63 Prev Close 1.68
Last Trade Volume 6,300 52 Wk Hi 1.85 52 Wk Low 0.85
Market Cap 172.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 105,490,544.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCPK